Provence Aaron, Malysz John, Petkov Georgi V
Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, South Carolina.
Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, South Carolina
J Pharmacol Exp Ther. 2015 Sep;354(3):290-301. doi: 10.1124/jpet.115.225268. Epub 2015 Jun 18.
The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca(2+) imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K(+) (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels.
电压门控性KV7通道亚型(KV7.1 - KV7.5)在逼尿肌平滑肌(DSM)中的生理作用目前了解甚少。在此,我们试图使用新型KV7.2/KV7.3通道激活剂ICA - 069673 [N - (2 - 氯 - 5 - 嘧啶基)-3,4 - 二氟苯甲酰胺]来阐明KV7.2/KV7.3通道在豚鼠DSM兴奋性和收缩性中的功能作用。我们采用了多层次实验方法,包括蛋白质印迹分析、免疫细胞化学、等长DSM张力记录、荧光Ca(2+)成像以及穿孔全细胞膜片钳电生理学。蛋白质印迹实验揭示了DSM组织中KV7.2和KV7.3通道亚基的蛋白表达。在分离的DSM细胞中,共聚焦显微镜免疫细胞化学进一步证实了KV7.2和KV7.3通道亚基的蛋白表达,它们定位于细胞膜附近。ICA - 069673以浓度依赖性方式抑制分离的DSM条带中的自发性相性收缩、药理学诱导的收缩以及神经诱发的收缩。在存在KV7通道抑制剂XE991 [10,10 - 双(4 - 吡啶基甲基)-9(10H)-蒽酮二盐酸盐]的情况下,ICA - 069673对DSM自发性相性和强直性收缩的抑制作用被消除。在细胞外K(+)升高(60 mM)的条件下,ICA - 069673对DSM强直性收缩的作用显著减弱。ICA - 069673降低了DSM细胞内的整体Ca(2+)浓度,L型Ca(2+)通道抑制剂硝苯地平可阻断这一作用。ICA - 069673使分离的DSM细胞的膜电位超极化并抑制自发性动作电位,在存在XE991的情况下这些作用被阻断。总之,本研究使用新型KV7.2/KV7.3通道激活剂ICA - 069673,为含KV7.2和KV7.3的通道在细胞和组织水平的DSM功能中起关键作用提供了有力证据。